Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Melanoma, Immunotherapy Europe

Caroline Robert

MD, PhD

🏢Institut Gustave Roussy🌐France

Professor, Head of Dermatology-Oncology Unit

78
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Caroline Robert is a leading European investigator in melanoma immunotherapy and led the KEYNOTE-006 trial that established pembrolizumab superiority over ipilimumab for advanced melanoma. Her research has evaluated adjuvant pembrolizumab for resected high-risk melanoma and explored the dermatologic manifestations of immune-related adverse events. She is among the most cited clinicians in the melanoma field.

Share:

🧪Research Fields 研究领域

melanoma immunotherapy Europe
pembrolizumab melanoma
ipilimumab CTLA-4 melanoma
nivolumab adjuvant melanoma
melanoma dermatology-oncology

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Caroline Robert 的研究动态

Follow Caroline Robert's research updates

留下邮箱,当我们发布与 Caroline Robert(Institut Gustave Roussy)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment